semaglutide fda changes GLP‑1 meds are reshaping obesity care — and now a pill is FDA‑approved for weight management. Want clear, evidence‑based info about cost, safety, compounding, and what this means for patients? Link American Federation of Medical Research

Published sensitization studies report rates below 1% in patch testing panels, and no carcinogenic or reproductive toxicity signals have emerged in long-term surveillance data

SeekPeptides members get access to detailed protocol comparisons, and here we break down the essential information every researcher needs

In Washington, our team works with your insurance to maximize coverage and connect you with savings programs and copay assistance

Novo Nordisk, the Danish company that makes Ozempic and Wegovy, says Australia is a high-priority market for its new weight-loss pill which went on sale in Britain this week, raising hopes the alternative to a weekly injection will be available by early next year

Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes: Preclinical Biology and Mechanisms of Action

Clinicians at Klinic are prepared to discuss the different necessities of orforglipron versus oral semaglutide and help you choose the right fit for your needs